Table 3.
TLR-4 polymorphism | Allele | Löfgren's syndrome n = 152 | Acute (incl. Löfgren's syndrome) n = 323 | Chronic sarcoidosis n = 680 | Acute and chronic sarcoidosis n = 938 | Control subjects n = 537 |
---|---|---|---|---|---|---|
(a) | ||||||
c.-4036A > G | 0 | 0 | 10 | 6 | 14 | 14 |
A | 220 (0·72) | 453 (0·71) | 981 (0·72) | 1343 (0·72) | 756 (0·71) | |
G | 84 (0·28) | 183 (0·29) | 373 (0·28) | 519 (0·28) | 304 (0·29) | |
c.94-837G > A | 0 | 4 | 12 | 30 | 40 | 12 |
A | 78 (0·26) | 150 (0·24) | 346 (0·26) | 464 (0·25) | 282 (0·27) | |
G | 222 (0·74) | 484 (0·76) | 984 (0·74) | 1372 (0·75) | 780 (0·73) | |
Asp299Gly | 0 | 2 | 6 | 8 | 14 | |
A | 283 (0·94) | 600 (0·94) | 1267 (0·94) | 1741 (0·94) | 1013 (0·94) | |
G | 19 (0·06) | 40 (0·06) | 85 (0·06) | 121 (0·06) | 61 (0·06) | |
Thr399Ile | 0 | 2 | 12 | 12 | 26 | 20 |
T | 23 (0·08) | 43 (0·07) | 91 (0·07) | 128 (0·07) | 62 (0·06) | |
C | 279 (0·92) | 591 (0·93) | 1257 (0·93) | 1722 (0·93) | 992 (0·94) | |
(b) | ||||||
c.-4036 A > G | 00 | 0 | 5 | 3 | 7 | 7 |
AA | 78 (0·51) | 155 (0·49) | 360 (0·53) | 485 (0·52) | 273 (0·51) | |
AG | 64 (0·42) | 143 (0·45) | 261 (0·39) | 373 (0·40) | 210 (0·40) | |
GG | 10 (0·07) | 20 (0·06) | 56 (0·08) | 73 (0·08) | 47 (0·09) | |
c.94–837G > A | 00 | 2 | 6 | 15 | 20 | 6 |
AA | 8 (0·05) | 14 (0·04) | 47 (0·07) | 56 (0·06) | 42 (0·08) | |
AG | 62 (0·41) | 122 (0·38) | 252 (0·38) | 352 (0·38) | 198 (0·37) | |
GG | 80 (0·53) | 181 (0·57) | 366 (0·55) | 510 (0·56) | 291 (0·55) | |
Asp299Gly | 00 | 1 | 3 | 4 | 7 | 0 |
AA | 132 (0·87) | 282 (0·88) | 592 (0·88) | 813 (0·87) | 479 (0·89) | |
AG | 19 (0·13) | 36 (0·11) | 83 (0·12) | 115 (0·12) | 55 (0·10) | |
GG | 0 (0·00) | 2 (0·01) | 1 (0·001) | 3 (0·003) | 3 (0·01) | |
Thr399Ile | 00 | 1 | 6 | 6 | 13 | 10 |
TT | 1 (0·01) | 3 (0·01) | 1 (0·001) | 5 (0·01) | 3 (0·01) | |
CT | 21 (0·14) | 37 (0·12) | 89 (0·13) | 118 (0·13) | 56 (0·11) | |
CC | 129 (0·85) | 277 (0·87) | 584 (0·87) | 802 (0·87) | 468 (0·89) |